Home

Concord Drugs Ltd EPS

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

EPS

₹ -0.04

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Concord Drugs Ltd is ₹ -0.04 as of 21 Feb 25 .
  • The earning per share of Concord Drugs Ltd changed from ₹ 0.53 to ₹ 0.23 over 7 quarters. This represents a CAGR of -37.94% .

Historical Earning per Share of Concord Drugs Ltd

No data available

* All values are in

Company Fundamentals for Concord Drugs Ltd

Market Cap

34 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

1.0

Day’s High

34.8

Day’s Low

33.12

DTE

0.6

ROE

-1.5

52 Week High

44.96

52 Week Low

28.5

ROCE

2.3

Market Price of Concord Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202534.64
20 Feb 202533.12
19 Feb 202534.31
18 Feb 202531.99
17 Feb 202533.65
14 Feb 202532.29
13 Feb 202532.72
12 Feb 202533.68
11 Feb 202531.56
10 Feb 202534.68

BlinkX Score for Concord Drugs Ltd

Asset Value vs Market Value of Concord Drugs Ltd

Market Value

35

-0.2 X

Value addition

Asset Value

45

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Concord Drugs Ltd34.64
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Concord Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Drugs Ltd News Hub

Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter

Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as again

Read more

10 Aug 24

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered

Read more

06 Aug 24

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September 2024. Powe

Read more

03 Sept 24

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept

Read more

19 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Concord Drugs Ltd

What is the EPS of Concord Drugs Ltd stock?

The Earnings Per Share (EPS) of Concord Drugs Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Concord Drugs Ltd EPS calculated?

The EPS of Concord Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Concord Drugs Ltd report its EPS?

Concord Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Concord Drugs Ltd EPS?

Factors that influence the EPS of Concord Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Concord Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Concord Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions